| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2003 | 2002年C型肝炎治療共識簡介 | JIA-HORNG KAO | 當代醫學 | | | |
| 1994 | A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients | JIA-HORNG KAO | Journal of Hepatology | | | |
| 2010 | A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection | JIA-HORNG KAO ; Tong, Myron John; Hsu, Leeyen; Hsien, Carlos; Kao, Jia-Horng ; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell | Hepatology International | | | |
| 2008 | A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | | | |
| 2018 | A noninvasive diagnosis of hepatic fibrosis by BioFibroScoreR in chronic hepatitis C patients | HUNG-CHIH YANG ; CHUN-JEN LIU ; CHEN-HUA LIU; CHUN-MING HONG ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | | | |
| 2010 | A novel antibody associated with autoimmune pancreatitis [4] | JIA-HORNG KAO | New England Journal of Medicine | | | |
| 2016 | A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection | Kao, Jia-Horng; JIA-HORNG KAO ; Ja-Ling Wu et al. | Liver International | | | |
| 2014 | A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin | DING-SHINN CHEN ; Hsu, Ching-Sheng; JIA-HORNG KAO ; Hsu, Shih-Jer; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn ; Kao, Jia-Horng | Journal of the Formosan Medical Association | | | |
| 2003 | A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | | | |
| 2015 | A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan | JIA-HORNG KAO | Hepatology International | | | |
| 2011 | Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers | JIN-CHUAN SHEU ; JIA-HORNG KAO ; NIEN, HSIAO-CHING; SHEU, JIN-CHUAN; KAO, JIA-HORNG ; CHOU, HUEI-CHI; SU, CHIEN-WEN; CHEN, CHIEN-HUNG | Journal of Medical Virology | | | |
| 1996 | Absence of extensive genetic heterogeneity of hepatitis C virus in antibody-negative chronic hepatitis C | JIA-HORNG KAO | Journal of Medical Virology | | | |
| 1995 | Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers | JIA-HORNG KAO | The Journal of Pediatrics | | | |
| 2018 | Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy | JIA-HORNG KAO | Radiology | | | |
| 2001 | Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus | PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | | | |
| 1997 | Acute pancreatitis complicated by infarction of the spleen and spinal cord | JIA-HORNG KAO | Journal of the Formosan Medical Association | | | |
| 2015 | Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection | DING-SHINN CHEN ; Hsu, Ching-Sheng; Liu, Wei-Liang; JIA-HORNG KAO ; Chao, You-Chen; Lin, Hans Hsienhong; Abbas, Z.; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn ; Kao, Jia-Horng | Hepatology International | | | |
| 2012 | Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals | JIA-HORNG KAO | Journal of Internal Medicine of Taiwan | | | |
| 2010 | Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link | JIA-HORNG KAO | American Journal of Gastroenterology | | | |
| 2015 | Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial | JIA-HORNG KAO | Journal of Viral Hepatitis | | | |
